109 related articles for article (PubMed ID: 24236158)
1. The anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) on the aggressive phenotypes of ovarian carcinoma cells.
Chen S; Zhao Y; Gou WF; Zhao S; Takano Y; Zheng HC
PLoS One; 2013; 8(11):e79781. PubMed ID: 24236158
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cells.
Zhou W; Feng X; Han Han ; Guo S; Wang G
Sci Rep; 2016 Jun; 6():28004. PubMed ID: 27292433
[TBL] [Abstract][Full Text] [Related]
3. KiSS-1 Modulation by Epigenetic Agents Improves the Cisplatin Sensitivity of Lung Cancer Cells.
Beretta GL; Alampi D; Corno C; Carenini N; Corna E; Perego P
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732265
[TBL] [Abstract][Full Text] [Related]
4. REST is a novel prognostic factor and therapeutic target for medulloblastoma.
Taylor P; Fangusaro J; Rajaram V; Goldman S; Helenowski IB; MacDonald T; Hasselblatt M; Riedemann L; Laureano A; Cooper L; Gopalakrishnan V
Mol Cancer Ther; 2012 Aug; 11(8):1713-1723. PubMed ID: 22848092
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells.
Chou PJ; Sarwar MS; Wang L; Wu R; Li S; Hudlikar RR; Wang Y; Su X; Kong AN
Cancer Prev Res (Phila); 2023 Jun; 16(6):321-332. PubMed ID: 36867722
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Modification Prevents Excessive Wound Healing and Scar Formation After Glaucoma Filtration Surgery.
Sharma A; Anumanthan G; Reyes M; Chen H; Brubaker JW; Siddiqui S; Gupta S; Rieger FG; Mohan RR
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3381-9. PubMed ID: 27367506
[TBL] [Abstract][Full Text] [Related]
7. Histone Deacetylase Inhibitor SAHA Improves High Salinity Tolerance Associated with Hyperacetylation-Enhancing Expression of Ion Homeostasis-Related Genes in Cotton.
He S; Hao Y; Zhang Q; Zhang P; Ji F; Cheng H; Lv D; Sun Y; Hao F; Miao C
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993126
[TBL] [Abstract][Full Text] [Related]
8. The histone deacetylase inhibitor vorinostat selectively sensitizes fibrosarcoma cells to chemotherapy.
Sampson ER; Amin V; Schwarz EM; O'Keefe RJ; Rosier RN
J Orthop Res; 2011 Apr; 29(4):623-32. PubMed ID: 20957741
[TBL] [Abstract][Full Text] [Related]
9. A unique histone deacetylase inhibitor alters microRNA expression and signal transduction in chemoresistant ovarian cancer cells.
Balch C; Naegeli K; Nam S; Ballard B; Hyslop A; Melki C; Reilly E; Hur MW; Nephew KP
Cancer Biol Ther; 2012 Jun; 13(8):681-93. PubMed ID: 22549158
[TBL] [Abstract][Full Text] [Related]
10. Improving therapeutic potential in breast cancer via histone deacetylase inhibitor loaded nanofibrils.
Senthilkumar P; Gogoi B; Dhan SS; Subramani R; Pushparaj C; Mahesh A
Drug Dev Res; 2024 Apr; 85(2):e22172. PubMed ID: 38488434
[TBL] [Abstract][Full Text] [Related]
11. Antileukemia activity of the combination of an anthracycline with a histone deacetylase inhibitor.
Sanchez-Gonzalez B; Yang H; Bueso-Ramos C; Hoshino K; Quintas-Cardama A; Richon VM; Garcia-Manero G
Blood; 2006 Aug; 108(4):1174-82. PubMed ID: 16675713
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable thermosensitive hydrogel for SAHA and DDP delivery: therapeutic effects on oral squamous cell carcinoma xenografts.
Li J; Gong C; Feng X; Zhou X; Xu X; Xie L; Wang R; Zhang D; Wang H; Deng P; Zhou M; Ji N; Zhou Y; Wang Y; Wang Z; Liao G; Geng N; Chu L; Qian Z; Wang Z; Chen Q
PLoS One; 2012; 7(4):e33860. PubMed ID: 22529899
[TBL] [Abstract][Full Text] [Related]
13. Sensitization of MCF7 Cells with High Notch1 Activity by Cisplatin and Histone Deacetylase Inhibitors Applied Together.
Wawruszak A; Luszczki J; Halasa M; Okon E; Landor S; Sahlgren C; Rivero-Muller A; Stepulak A
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068438
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition.
Jonsson M; Ragnum HB; Julin CH; Yeramian A; Clancy T; Frikstad KM; Seierstad T; Stokke T; Matias-Guiu X; Ree AH; Flatmark K; Lyng H
Br J Cancer; 2016 Oct; 115(8):929-939. PubMed ID: 27599042
[TBL] [Abstract][Full Text] [Related]
15. Histone modifications silence the GATA transcription factor genes in ovarian cancer.
Caslini C; Capo-chichi CD; Roland IH; Nicolas E; Yeung AT; Xu XX
Oncogene; 2006 Aug; 25(39):5446-61. PubMed ID: 16607277
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of a novel histone deacetylase inhibitor, LAQ824, in human colon carcinoma cells and xenografts.
Chung YL; Troy H; Kristeleit R; Aherne W; Jackson LE; Atadja P; Griffiths JR; Judson IR; Workman P; Leach MO; Beloueche-Babari M
Neoplasia; 2008 Apr; 10(4):303-13. PubMed ID: 18392140
[TBL] [Abstract][Full Text] [Related]
17. Selenium-containing histone deacetylase inhibitors for melanoma management.
Gowda R; Madhunapantula SV; Desai D; Amin S; Robertson GP
Cancer Biol Ther; 2012 Jul; 13(9):756-65. PubMed ID: 22669577
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic Therapies in Ovarian Cancer Alter Repetitive Element Expression in a
McDonald JI; Diab N; Arthofer E; Hadley M; Kanholm T; Rentia U; Gomez S; Yu A; Grundy EE; Cox O; Topper MJ; Xing X; Strissel PL; Strick R; Wang T; Baylin SB; Chiappinelli KB
Cancer Res; 2021 Oct; 81(20):5176-5189. PubMed ID: 34433584
[TBL] [Abstract][Full Text] [Related]
19. Targeting Tumorigenicity of Breast Cancer Stem Cells Using SAHA/Wnt-b Catenin Antagonist Loaded Onto Protein Corona of Gold Nanoparticles.
Shamsian A; Sepand MR; Javaheri Kachousangi M; Dara T; Ostad SN; Atyabi F; Ghahremani MH
Int J Nanomedicine; 2020; 15():4063-4078. PubMed ID: 32606664
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 expression, proliferative and apoptotic activities in ovarian epithelial inclusions.
Wang Y; Wang Y; Wei L; Hong S; Zhao M; Zhang X; Zheng W
J Ovarian Res; 2017 Mar; 10(1):12. PubMed ID: 28270171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]